Supplementary Methods and Figure 1 from The Novel Polyamine Analogue CGC-11093 Enhances the Antimyeloma Activity of Bortezomib
Jennifer S. Carew(University of Arizona), John L. Cleveland(Moffitt Cancer Center), Robert A. Casero(Harvard University), Andrew L. Goodwin(University of Oxford), Janet A. Houghton(Cleveland Clinic), Venudhar K. Reddy, Laurence J. Marton, Jerold E. Rehg(St. Jude Children's Research Hospital), Dorothy Bush(St. Jude Children's Research Hospital), Steffan T. Nawrocki(University of Arizona)
Cited by 0
Related Papers
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
|Autophagy|2008|2k
Targeting lactate metabolism for cancer therapeutics
|Journal of Clinical Investigation|2013|1.2k
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
|Clinical Cancer Research|2008|782
Correlated defect nanoregions in a metal–organic framework
|Nature Communications|2014|732
Subtype and pathway specific responses to anticancer compounds in breast cancer
|Proceedings of the National Academy of Sciences|2011|505